Genesis Healthcare, Inc.
GENN
$0.0002
$0.000.00%
| 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | 12/31/2019 | |
|---|---|---|---|---|---|
| Revenue | -19.06% | -16.47% | -16.49% | -5.97% | -4.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.06% | -16.47% | -16.49% | -5.97% | -4.26% |
| Cost of Revenue | -12.12% | -13.78% | -1.47% | -9.63% | -10.35% |
| Gross Profit | -26.72% | -19.79% | -34.61% | -1.45% | 3.52% |
| SG&A Expenses | 0.76% | -5.12% | 1.55% | 17.13% | 119.65% |
| Depreciation & Amortization | 8.69% | -30.23% | 19.63% | -31.96% | -58.83% |
| Other Operating Expenses | -16.62% | -8.21% | -3.65% | -4.73% | -1.49% |
| Total Operating Expenses | -11.42% | -11.53% | -1.16% | -5.91% | -2.19% |
| Operating Income | -414.01% | -769.49% | -629.32% | -14.52% | -54.28% |
| Income Before Tax | -29.66% | -264.16% | -225.57% | 251.42% | 86.39% |
| Income Tax Expenses | -204.77% | 130.93% | -182.10% | -1,627.45% | 466.57% |
| Earnings from Continuing Operations | 3.21% | -262.87% | -226.35% | 254.22% | 84.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 53.09% | 358.86% | 75.58% | -152.68% | -85.10% |
| Net Income | 32.67% | -236.22% | -356.63% | 319.54% | 83.47% |
| EBIT | -414.01% | -769.49% | -629.32% | -14.52% | -54.28% |
| EBITDA | -201.56% | -234.56% | -303.00% | -28.66% | -43.67% |
| EPS Basic | 35.03% | -231.39% | -338.58% | 307.47% | 84.49% |
| Normalized Basic EPS | -1,422.87% | 56.21% | -870.75% | -35.81% | -231.07% |
| EPS Diluted | 55.78% | -239.03% | -300.00% | 258.40% | 76.07% |
| Normalized Diluted EPS | -1,422.87% | 33.39% | -870.75% | 11.03% | -231.07% |
| Average Basic Shares Outstanding | 3.57% | 3.69% | 4.10% | 5.79% | 6.58% |
| Average Diluted Shares Outstanding | 3.57% | -31.84% | 4.10% | 61.42% | 6.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
